This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 2 EPO patents. Top assignees: Paratek Pharmaceuticals, Inc., Tufts University. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2011
Title: The Innovative Contributions of Jimmy Dumornay
Introduction
Jimmy Dumornay is a notable inventor based in Walpole, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his work on minocycline compounds. His innovative approach has the potential to address various medical challenges.
Latest Patents
Dumornay holds a patent for 9-substituted minocycline compounds. This invention pertains to novel compounds that can be utilized to treat numerous tetracycline compound-responsive states. These include bacterial infections and neoplasms, as well as other applications for minocycline and tetracycline compounds, such as blocking tetracycline efflux and modulation of gene expression.
Career Highlights
Throughout his career, Dumornay has worked with esteemed institutions, including Tufts College and Paratek Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.
Collaborations
Dumornay has collaborated with notable colleagues, including Mark L Nelson and Roger Frechette. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Jimmy Dumornay's work in developing 9-substituted minocycline compounds showcases his innovative spirit and dedication to improving medical treatments. His contributions to the field of pharmaceuticals are commendable and have the potential to make a significant impact.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile